Management: The New Competitive Landscape with CD and PowerWeb - Tapa dura

Acerca de los autores

Thomas Bateman earned his B.A. from Miami University, and his Ph.D. in business administration from Indiana University. He is Bank of America professor and management area coordinator in the McIntire School of Commerce at the University of Virginia, teaching leadership and organizational behavior. Dr. Bateman taught at Kenan-Flagler Business School of the University of North Carolina and for two years in Europe at the Institute of Management Development, a world leader in design and delivery of executive education. He is an active management researcher, writer, and consultant, and serves on the editorial boards of several prestigious journals. His articles appear in professional journals such as the Academy of Management Journal, Academy of Management Review, and Proceedings of the National Academy of Sciences. Dr. Bateman's research interests center on proactive behavior by employees at all levels, with a recent turn toward scientists and public leadership.

Scott Snell received his B.A. in psychology from Miami University, and his M.B.A. and Ph.D. in business administration from Michigan State University. He is a professor at the University of Virginia's Darden Graduate School of Business. Before joining Darden, he was professor and director of executive education at Cornell's University's Center for Advanced Human Resource Studies and a professor of management in the Smeal College of Business at Penn State University. Dr. Snell's research focuses on human resources and the mechanisms by which organizations generate, transfer, and integrate new knowledge for competitive advantage. He recently was listed among the top 100 most-cited authors in scholarly journals of management. Dr. Snell is co-author of four books, and his work has been published in a number of journals, such as the Academy of Management Journal. Dr. Snell has served on boards of several organizations and journals and worked with such companies as AstraZeneca and Shell.